A Clinical Trial to Assess the Pharmacokinetics, Safety, and Food Effect of AD-230 in Healthy Adults

Trial statusNot yet recruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

Age19-64

SponsorAddpharma Inc.

About this trial

A clinical trial to assess the pharmacokinetics, safety, and food effect of AD-230 in healthy adults

Body mass index (BMI) between 18.5 kg/m2 and 29.9 kg/m2 at the time of screening visit

Subjects aged 19 years or older and under 65 years at the screening visit

Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration

Other exclusions applied

24 Participants

are divided into 2 treatment groups

Addpharma Inc.

Lead sponsor